Investigator
Artem Barski
DATIRIUM, LLC · funded by NIAID
- Companies
- 2
- Grants
- 3
- Non-dilutive funding
- $1.2M
- First award
- Mar 8, 2021
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
Latest Jan 6, 2025.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- DATIRIUM, LLCMomentum in another area
ImmunologyGrant-only
- DATIRIUM, LLCMomentum in another area
ImmunologyGrant-only
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- R41
Bioinformatics pipeline for personalized diagnostics of transplant rejection
$307kJan 6, 2025NIAIDDATIRIUM, LLCNIH RePORTER · 11069619 (opens the source filing in a new tab)
- R41
Bioinformatics pipeline for personalized diagnostics of transplant rejection
$307kJan 6, 2025NIAIDDATIRIUM, LLCNIH RePORTER · 11254890 (opens the source filing in a new tab)
- R01
An experimentally-refined, dynamic gene regulatory network model of T-cell memory
$633kMar 8, 2021NIAIDCINCINNATI CHILDRENS HOSP MED CTRNIH RePORTER · 11042256 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources